Table 5.
Identifying patients with HFpEF and obesity in overall HFpEF spectrum and patients with obesity.
| Variables | Differentiate patients with HFpEF and obesity from overall patients with HFpEF (n = 79) |
Differentiate with HFpEF and obesity from patients with obesity (n = 77) |
||||
|---|---|---|---|---|---|---|
| AUC | 95%CI | p-value | AUC | 95%CI | p-value | |
| LVEF | 0.656 | 0.516–0.797 | 0.035 | 0.773 | 0.650–0.896 | 0.0004 |
| LAVi | 0.649 | 0.512–0.786 | 0.045 | 0.615 | 0.485–0.744 | 0.14 |
| LVEDVi | 0.652 | 0.517–0.788 | 0.040 | 0.736 | 0.617–0.855 | 0.0021 |
| LVESVi | 0.686 | 0.550–0.822 | 0.012 | 0.783 | 0.671–0.895 | 0.0002 |
| LVMi | 0.836 | 0.731–0.940 | <0.0001 | 0.711 | 0.599–0.824 | 0.0059 |
| GLS | 0.709 | 0.582–0.837 | 0.005 | 0.912 | 0.833–0.991 | <0.0001 |
| GCS | 0.722 | 0.600–0.843 | 0.0027 | 0.890 | 0.802–0.979 | <0.0001 |
| GRS | 0.733 | 0.614–0.852 | 0.0017 | 0.878 | 0.786–0.971 | <0.0001 |
| eGLSR | 0.554 | 0.406–0.702 | 0.46 | 0.749 | 0.636–0.863 | 0.0012 |
| ECV | 0.526 | 0.391–0.661 | 0.73 | 0.746 | 0.616–0.875 | 0.0014 |
Bold P-values indicate a significance level of <0.05.
AUC, area under the ROC curves; CI, confidence interval; LV, left ventricular; EDVi/ESVi, end-diastole/systole volume index; LVMi, LV end-diastolic mass/height2.7; LAVi, left atrial maximal volume index; GLS, GCS, and GRS, global longitudinal, circumferential, radial strain; eGLSR, early-diastolic GLS rate; ECV, extracellular volume fraction.